FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37831263> ?p ?o ?g. }

• Q37831263 description "article científic" @default.
• Q37831263 description "article scientifique" @default.
• Q37831263 description "articolo scientifico" @default.
• Q37831263 description "artigo científico" @default.
• Q37831263 description "artículu científicu espublizáu en 2011" @default.
• Q37831263 description "bilimsel makale" @default.
• Q37831263 description "scientific article published on 20 January 2011" @default.
• Q37831263 description "vedecký článok" @default.
• Q37831263 description "vetenskaplig artikel" @default.
• Q37831263 description "videnskabelig artikel" @default.
• Q37831263 description "vědecký článek" @default.
• Q37831263 description "wetenschappelijk artikel" @default.
• Q37831263 description "wissenschaftlicher Artikel" @default.
• Q37831263 description "наукова стаття, опублікована в січні 2011" @default.
• Q37831263 description "научни чланак" @default.
• Q37831263 description "مقالة علمية نشرت في 20 يناير 2011" @default.
• Q37831263 name "Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review" @default.
• Q37831263 name "Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review" @default.
• Q37831263 name "Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review" @default.
• Q37831263 type Item @default.
• Q37831263 label "Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review" @default.
• Q37831263 label "Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review" @default.
• Q37831263 label "Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review" @default.
• Q37831263 prefLabel "Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review" @default.
• Q37831263 prefLabel "Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review" @default.
• Q37831263 prefLabel "Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review" @default.
• Q37831263 P1433 Q37831263-DC68128C-182D-4146-AC3E-0AC08C870FAF @default.
• Q37831263 P1476 Q37831263-E535F694-1CB5-4D00-A17F-86D31C129A30 @default.
• Q37831263 P2093 Q37831263-2BE1F7A7-C5F9-4503-B219-A7D48323BFAC @default.
• Q37831263 P2093 Q37831263-38A60CD1-BA1C-4B25-9807-B4676E368D44 @default.
• Q37831263 P2093 Q37831263-59E205F4-8112-4831-88B5-A8136877565E @default.
• Q37831263 P2093 Q37831263-EDB839D6-2451-46FE-BE8D-0EADB66122C4 @default.
• Q37831263 P2860 Q37831263-0ED267DE-D7BC-434E-963F-09CB94CCF9C5 @default.
• Q37831263 P2860 Q37831263-10CBC749-456C-4BDF-B5D3-113CD85601F8 @default.
• Q37831263 P2860 Q37831263-124FD63C-7D85-423A-A14F-D5FBCAAEEAF5 @default.
• Q37831263 P2860 Q37831263-1849887D-C52D-432E-9514-3B8027C0EAE5 @default.
• Q37831263 P2860 Q37831263-1D22E688-0C48-47CD-9A6B-A301FEFA298D @default.
• Q37831263 P2860 Q37831263-1F82E447-8A55-4185-9AFE-DA236AA15B73 @default.
• Q37831263 P2860 Q37831263-22C7F8B1-922E-4303-8F8A-16DE686F84A0 @default.
• Q37831263 P2860 Q37831263-23C70299-D867-4F78-957C-A82EEAB4B81A @default.
• Q37831263 P2860 Q37831263-2ECECB54-82FB-4523-99DD-93578F234265 @default.
• Q37831263 P2860 Q37831263-37236822-0B4E-44F1-B484-34E527A82F35 @default.
• Q37831263 P2860 Q37831263-5DCF1863-B03D-4EBB-BF84-44C8512F7C23 @default.
• Q37831263 P2860 Q37831263-70CB6E7F-1DE8-493B-A98A-1CAFDC7CCDE5 @default.
• Q37831263 P2860 Q37831263-990419EA-B7EF-4870-82CB-8CB414A587C2 @default.
• Q37831263 P2860 Q37831263-A383F9E2-705A-42DB-856C-493D3F8E2988 @default.
• Q37831263 P2860 Q37831263-A9572078-AA43-49B7-AC08-1704154109C9 @default.
• Q37831263 P2860 Q37831263-C2C53D90-8601-4D4F-8682-6724F48013A7 @default.
• Q37831263 P2860 Q37831263-C677D6AD-A30E-468C-AD77-C7C2B436751A @default.
• Q37831263 P2860 Q37831263-D490803F-76B5-463A-B517-DA141FBCA6B8 @default.
• Q37831263 P2860 Q37831263-D675FB53-8F4E-44F9-8928-6A9626AFDD35 @default.
• Q37831263 P2860 Q37831263-DDE87011-D3FC-4434-92C2-C975A84C07DE @default.
• Q37831263 P2860 Q37831263-E836ADF4-DECA-4D7F-917F-04F204A3DC18 @default.
• Q37831263 P2860 Q37831263-EE699780-3FBE-4BF6-83C2-74334E3A4C74 @default.
• Q37831263 P304 Q37831263-63A87F67-B7D5-4B6F-99B0-576B39CEC1E6 @default.
• Q37831263 P31 Q37831263-22943dd2-7f4d-4bf2-918f-dc5df6f6ef3f @default.
• Q37831263 P31 Q37831263-774A956A-6847-4635-A46A-FBB5D39A775F @default.
• Q37831263 P356 Q37831263-1580370E-0552-4A4B-B99C-DFB307AD40E9 @default.
• Q37831263 P433 Q37831263-1321E6D4-972C-46D1-B54F-13DCEB5F51F9 @default.
• Q37831263 P478 Q37831263-C06E6651-46AF-475D-905A-CB4AD00EB58E @default.
• Q37831263 P50 Q37831263-57B75D45-2ADC-47C3-8BE1-3C0C687451E3 @default.
• Q37831263 P577 Q37831263-E4C6705A-58DF-4A4F-952F-A8C664ACB7D5 @default.
• Q37831263 P698 Q37831263-92DAF708-93A6-4E89-A42A-74325D79B69C @default.
• Q37831263 P921 Q37831263-0D3A6EA7-DF62-4CA0-A4A9-AE92A4904816 @default.
• Q37831263 P356 NAU.21051 @default.
• Q37831263 P698 21254199 @default.
• Q37831263 P1433 Q15753354 @default.
• Q37831263 P1476 "Falls risk reduction and treatment of overactive bladder symptoms with antimuscarinic agents: a scoping review" @default.
• Q37831263 P2093 "Adrian Wagg" @default.
• Q37831263 P2093 "Hope Chick" @default.
• Q37831263 P2093 "Kathleen F Hunter" @default.
• Q37831263 P2093 "Teresa Kerridge" @default.
• Q37831263 P2860 Q24570441 @default.
• Q37831263 P2860 Q28202479 @default.
• Q37831263 P2860 Q34104256 @default.
• Q37831263 P2860 Q34699525 @default.
• Q37831263 P2860 Q35807519 @default.
• Q37831263 P2860 Q35827398 @default.
• Q37831263 P2860 Q36024379 @default.
• Q37831263 P2860 Q36201756 @default.
• Q37831263 P2860 Q36362859 @default.
• Q37831263 P2860 Q36622649 @default.
• Q37831263 P2860 Q36722436 @default.
• Q37831263 P2860 Q36791068 @default.
• Q37831263 P2860 Q37127755 @default.
• Q37831263 P2860 Q37186666 @default.
• Q37831263 P2860 Q37242704 @default.
• Q37831263 P2860 Q37505239 @default.
• Q37831263 P2860 Q37634389 @default.
• Q37831263 P2860 Q39916054 @default.
• Q37831263 P2860 Q40103109 @default.
• Q37831263 P2860 Q43277955 @default.
• Q37831263 P2860 Q48477052 @default.
• Q37831263 P2860 Q51950637 @default.
• Q37831263 P304 "490-494" @default.
• Q37831263 P31 Q13442814 @default.
• Q37831263 P31 Q7318358 @default.
• Q37831263 P356 "10.1002/NAU.21051" @default.
• Q37831263 P433 "4" @default.
• Q37831263 P478 "30" @default.

• next